Drug Type CAR-T |
Synonyms PRO-CAR-202A |
Target |
Action modulators |
Mechanism IL-18 modulators(Interleukin 18 modulators), STEAP1 modulators(Six-transmembrane epithelial antigen of the prostate 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic castration-resistant prostate cancer | Preclinical | United States | 01 Mar 2026 |





